Cargando…
The Endothelium as a Target for Anti-Atherogenic Therapy: A Focus on the Epigenetic Enzymes EZH2 and SIRT1
Endothelial cell inflammatory activation and dysfunction are key events in the pathophysiology of atherosclerosis, and are associated with an elevated risk of cardiovascular events. Yet, therapies specifically targeting the endothelium and atherosclerosis are lacking. Here, we review how endothelial...
Autores principales: | Fledderus, Jolien, Vanchin, Byambasuren, Rots, Marianne G., Krenning, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915331/ https://www.ncbi.nlm.nih.gov/pubmed/33562658 http://dx.doi.org/10.3390/jpm11020103 |
Ejemplares similares
-
The decrease in histone methyltransferase EZH2 in response to fluid shear stress alters endothelial gene expression and promotes quiescence
por: Maleszewska, Monika, et al.
Publicado: (2015) -
Reciprocal regulation of endothelial–mesenchymal transition by MAPK7 and EZH2 in intimal hyperplasia and coronary artery disease
por: Vanchin, Byambasuren, et al.
Publicado: (2021) -
Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions -Targeted siRNA delivery to pro-atherogenic endothelium in vivo
por: Chung, Jihwa, et al.
Publicado: (2016) -
MicroRNA‐374b induces endothelial‐to‐mesenchymal transition and early lesion formation through the inhibition of MAPK7 signaling
por: Vanchin, Byambasuren, et al.
Publicado: (2019) -
Atherogenic Factors and Their Epigenetic Relationships
por: Fernandez, Ana Z., et al.
Publicado: (2010)